Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease ...
Learn more about whether The Buckle, Inc. or Five Below, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.